Dermorphin is a heptapeptide that has been isolated for the first time from the skin of South American frogs belonging to the genus Euphorbia. It is a natural opioid substance that binds as an agonist μ Opioid receptors (MORs) have high potency and selectivity. Its amino acid sequence is H-Tyr D-Ala Phe Gly Tyr Pro Ser NH2. Dermorphin has not been found in the skin of humans or other mammals, while similar D-amino acid peptides are only found in bacteria, amphibians, and mollusks. This means that it is produced through unusual post translational modifications under the action of amino acid isomerases. This process is the main reason for its efficiency and selectivity, as the D-alanine in the peptide is not included in the 20 amino acids encoded in the genetic code, so the peptide cannot be synthesized from the coding in the biological genome in the usual way.
In addition, in some aspects, Dermorphin has similar functions to morphine. It can be used to suppress neuralgia, although its mechanism of action is not entirely clear. However, as an opioid receptor agonist, it may be activated by μ Opioid receptors (MORs) are used to suppress pain.
link1:https://www.bloomtechz.com/synthetic-chemical/peptide/dermorphin-acetate-cas-77614-16-5.html
link2:https://www.bloomtechz.com/synthetic-chemical/peptide/dermorphin-in-humans-cas-77614-16-5.html
link3:https://www.bloomtechz.com/synthetic-chemical/peptide/dermorphin-peptide-cas-77614-16-5.html
Dermorphin is a natural peptide substance with multiple biological functions.
1. Analgesic effect: Dermorphin is a natural peptide substance with multiple biological functions, the most important of which is its analgesic effect. It has a strong analgesic effect, especially showing good therapeutic effects on chronic pain, neuropathic pain, and inflammatory pain. Its mechanism of action is mainly achieved by interacting with opioid receptors (especially μ The interaction between opioid receptors inhibits the release of neurotransmitters, thereby exerting analgesic effects.
The analgesic effect of Dermorphin is mainly mediated by its interaction with opioid receptors (especially μ The interaction between opioid receptors is achieved.
(1) Analgesic mechanism: Dermorphin and μ Opioid receptors have high affinity and exert analgesic effects by inhibiting the release of neurotransmitters through interactions with receptors. Compared with other opioid drugs, Dermorphin has stronger analgesic effects and higher specificity.
(2) Analgesic effect: Dermorphin's analgesic effect is highly effective and long-lasting. In animal models, its analgesic effect can last for several hours and exhibits good therapeutic effects on different types of pain. In clinical studies, Dermorphin has been shown to significantly alleviate various types of pain, including postoperative pain, neuropathic pain, and inflammatory pain.
(3) Resistance: Compared to other opioid drugs, Dermorphin has lower resistance. Long term use of Dermorphin does not cause the body to develop resistance to it, thus ensuring the durability of the analgesic effect.
(4) Adverse reactions: The analgesic effect of Dermorphin may lead to some adverse reactions, such as respiratory depression, constipation, and drowsiness. However, compared to other opioid drugs, Dermorphin has a lower incidence and milder degree of adverse reactions.
(5) Synthesis and preparation: Dermorphin is a natural peptide substance that can be isolated from the skin of South American frogs. However, due to its limited production capacity, it cannot meet clinical needs. Therefore, scientists have successfully synthesized analogues and derivatives of Dermorphin, which have higher stability and analgesic activity.
In summary, the analgesic effect of Dermorphin has high efficiency, persistence, and specificity, can alleviate various types of pain, and has a low incidence of adverse reactions. However, due to its limited production capacity, it cannot meet clinical needs. In the future, this problem can be solved by synthesizing and preparing highly active Dermorphin analogues and derivatives, providing more options for clinical analgesic treatment. It should be noted that the use of Dermorphin or related drugs should follow the advice and guidance of a professional doctor.
2. Anti tumor effect: research has found that Dermorphin has inhibitory effect on a variety of tumor cells, such as human breast cancer cells, human glioma cells, etc. Its anti-tumor effect mainly involves inducing tumor cell apoptosis, inhibiting tumor cell proliferation and invasion and metastasis ability.
3. Anti inflammatory effects: Dermorphin is a natural peptide substance with multiple biological functions, including anti-inflammatory effects. The anti-inflammatory effect of Dermorphin is mainly achieved by inhibiting the activation of inflammatory cells and the release of inflammatory factors. It has obvious anti-inflammatory effects and can inhibit the activation of inflammatory cells and the release of inflammatory factors. In inflammatory disease models, Dermorphin can alleviate inflammatory reactions and alleviate inflammatory symptoms.
(1) Anti inflammatory mechanism: Dermorphin's anti-inflammatory effect is mainly achieved by inhibiting the activation of inflammatory cells and the release of inflammatory factors. Research has shown that Dermorphin can inhibit the activation, chemotaxis, and infiltration of inflammatory cells such as macrophages, neutrophils, and lymphocytes, thereby reducing inflammatory responses. In addition, Dermorphin can also inhibit the release of inflammatory factors such as tumor necrosis factor (TNF)- α）、 Interleukins (IL-1, IL-6, and IL-8) and chemokines.
(2) Anti inflammatory effect: Dermorphin's anti-inflammatory effect has been validated in various inflammatory disease models. In animal models, Dermorphin can alleviate inflammatory reactions, reduce the infiltration of inflammatory cells in the inflammatory site, and alleviate inflammatory symptoms. For example, in an acute inflammation model, Dermorphin can alleviate symptoms such as redness, swelling, fever, and pain in the inflamed area. In chronic inflammatory disease models, Dermorphin can alleviate the progression of inflammation, alleviate tissue damage and dysfunction.
(3) The relationship between anti-inflammatory and analgesic effects: There is a certain correlation between the anti-inflammatory and analgesic effects of Dermorphin. Some studies have shown that the anti-inflammatory effect of Dermorphin can indirectly promote its analgesic effect. By inhibiting the inflammatory response, Dermorphin can reduce the onset and duration of inflammatory pain. In addition, Dermorphin can also inhibit the transmission of pain signals, thereby exerting analgesic effects.
4. Immunomodulatory effect: Dermorphin has a regulatory effect on the immune system, inhibiting inflammatory immune responses and alleviating symptoms of autoimmune diseases. In autoimmune disease models, Dermorphin can reduce the intensity of the autoimmune response and alleviate disease symptoms.
5. Anti anxiety effect: Research has found that Dermorphin has an anti anxiety effect, which can reduce anxiety behavior and stress response. Its anti anxiety effect may be related to μ The excitatory effect of opioid receptors is related.
6. Neuroprotective effect: Dermorphin has a protective effect on the nervous system, which can protect neurons from damage. In neurological disease models, Dermorphin can alleviate neuronal damage, promote nerve regeneration, and functional recovery.
7. Cardiovascular system effects: Dermorphin has a certain impact on the cardiovascular system, which can cause effects such as increased blood pressure and decreased heart rate. These effects may be related to μ The excitatory effect of opioid receptors is related.
It should be noted that more in-depth and comprehensive research on Dermorphin is still ongoing, and its clinical application prospects and potential side effects require further exploration. Therefore, when using Dermorphin or related drugs, it is important to follow the advice and guidance of a professional doctor.